Medtronic Unveils Percept™ RC, the World’s Smallest Smart, Sensing and Rechargeable Deep Brain Stimulation System, at CIIE

China Finance and Economics News, November 7th: At the 7th China International Import Expo (CIIE), Medtronic, with the theme "Further Beauty, Uncommon Together," showcased nearly a hundred innovative products and technologies for the seventh consecutive year.

The World's Smallest Smart Perceptible and Rechargeable Brain Pacemaker: Percept^™RC Debuts as "Asia-Pacific Premiere" Product at the CIIE Stage.

It is reported that Medtronic's intelligent, perceptible, and rechargeable brain pacemaker Percept^™RC is the latest and revolutionary deep brain stimulation (DBS) product globally, significantly advancing the progress of personalized and precise treatment with brain stimulators. The product has received approval from the U.S. FDA and EU CE and is widely used in clinical applications overseas.

Deep Brain Stimulation (DBS), commonly known as a "brain pacemaker," involves the implantation of fine electrodes into the brain that emit electrical pulses to stimulate specific nuclei deep within the brain, thereby alleviating patients' disease symptoms. It is a neuro-modulation technology used to treat neurological disorders such as Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy, characterized by being "minimally invasive," "reversible," and "adjustable."

According to the introduction, Percept^™ The development and application of RC have pushed the personalized precision treatment process for diseases such as Parkinson's disease to new heights. Compared with traditional brain pacemakers, it has achieved all-round technological breakthroughs. In the future, patients will be able to activate closed-loop stimulation of the brain pacemaker through software upgrades, realizing personalized precision treatment and improving quality of life.

At the Medtronic Neuromodulation exhibition area, the world's first directional lead system with sensing capabilities, SenSight^™Also made its debut at the CIIE after being clinically applied in China. The directional electrode system, used in conjunction with the brain pacemaker, can continuously enhance patient benefits and treatment experience through powerful directional stimulation, brain sensing technology, and richer and more efficient programming functions.

Chen Jianrong, Senior Director of Medtronic's Neuromodulation Business in Greater China, stated that this year marks the 75th anniversary of Medtronic's global establishment, the 35th year of its deep involvement in China, and the 25th anniversary of Medtronic Neuromodulation's partnership with China. "Over the past seven years, many of our innovative technologies have leveraged the powerful spillover effects and influence of the CIIE to transform exhibits into products, benefiting countless families. We look forward to Percept."^™"RC, this 'treasure' product that showcases new medical productivity, can accelerate its introduction into China, helping patients suffering from neurological disorders such as Parkinson's disease to 'reduce pain, restore health, and prolong life.'"